T1	Premise 1116 1219	The response rates, QOL, and median RD, TTP, and TTF were not significantly different between the arms.
T2	Premise 1220 1293	Median OS was 13.8 months for arm 1 versus 14.4 months for arm 2 (P =.4).
T3	Premise 1294 1434	Grade 3 or 4 granulocytopenia was equivalent in both arms but more grade 3/4 neurotoxicity, mild venous toxicity, and FN were seen on arm 1.
T4	Claim 1435 1501	The survival with DOX and VNB is not superior to DOX alone in MBC.
R1	Support Arg1:T1 Arg2:T4	
R2	Support Arg1:T2 Arg2:T4	
